

How to buy Ocular Therapeutix stock | $14.56

Learn how to easily invest in Ocular Therapeutix stock.

Ocular Therapeutix, Inc is a biotechnology business based in the US. Ocular Therapeutix shares (OCUL) are listed on the NASDAQ and all prices are listed in US Dollars. Ocular Therapeutix employs 181 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Ocular Therapeutix

  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OCUL – and research it before deciding if it's a good investment for you.

Ocular Therapeutix stock price (NASDAQ: OCUL)

Use our graph to track the performance of OCUL stocks over time.

Ocular Therapeutix shares at a glance

Information last updated 2021-07-23.
Latest market close$14.56
52-week range$7.14 - $24.30
50-day moving average $13.70
200-day moving average $16.77
Wall St. target price$25.33
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.79

Buy Ocular Therapeutix shares from these brokerages

Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Open an account
Stocks, ETFs
$0 per month
Open an account
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Sign up using the "go to site" link
Stocks, Options, ETFs
$0 per year

Compare up to 4 providers

*Signup bonus information updated weekly.


Is it a good time to buy Ocular Therapeutix stock?



Ocular Therapeutix price performance over time

Historical closes compared with the close of $14.56 from 2021-05-28

1 week (2021-07-18) N/A
1 month (2021-06-29) 5.81%
3 months (2021-04-29) -24.01%
6 months (2021-01-25) N/A
1 year (2020-07-25) N/A
2 years (2019-07-25) N/A
3 years (2018-07-25) N/A
5 years (2016-07-25) N/A

Ocular Therapeutix financials

Revenue TTM $22.1 million
Gross profit TTM $-13,374,000
Return on assets TTM -26.3%
Return on equity TTM -360.15%
Profit margin 0%
Book value $1.09
Market capitalisation $924.7 million

TTM: trailing 12 months

Shorting Ocular Therapeutix shares

There are currently 5.8 million Ocular Therapeutix shares held short by investors – that's known as Ocular Therapeutix's "short interest". This figure is 10% down from 6.5 million last month.

There are a few different ways that this level of interest in shorting Ocular Therapeutix shares can be evaluated.

Ocular Therapeutix's "short interest ratio" (SIR)

Ocular Therapeutix's "short interest ratio" (SIR) is the quantity of Ocular Therapeutix shares currently shorted divided by the average quantity of Ocular Therapeutix shares traded daily (recently around 813597.33893557). Ocular Therapeutix's SIR currently stands at 7.14. In other words for every 100,000 Ocular Therapeutix shares traded daily on the market, roughly 7140 shares are currently held short.

However Ocular Therapeutix's short interest can also be evaluated against the total number of Ocular Therapeutix shares, or, against the total number of tradable Ocular Therapeutix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ocular Therapeutix's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Ocular Therapeutix shares in existence, roughly 80 shares are currently held short) or 0.0869% of the tradable shares (for every 100,000 tradable Ocular Therapeutix shares, roughly 87 shares are currently held short).


Find out more about how you can short Ocular Therapeutix stock.

Ocular Therapeutix share dividends

We're not expecting Ocular Therapeutix to pay a dividend over the next 12 months.

Ocular Therapeutix share price volatility

Over the last 12 months, Ocular Therapeutix's shares have ranged in value from as little as $7.14 up to $24.3. A popular way to gauge a stock's volatility is its "beta".

OCUL.US volatility(beta: 2.06)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ocular Therapeutix's is 2.0598. This would suggest that Ocular Therapeutix's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Ocular Therapeutix overview


Frequently asked questions

What percentage of Ocular Therapeutix is owned by insiders or institutions?
Currently 0.463% of Ocular Therapeutix shares are held by insiders and 63.668% by institutions.
How many people work for Ocular Therapeutix?
Latest data suggests 181 work at Ocular Therapeutix.
When does the fiscal year end for Ocular Therapeutix?
Ocular Therapeutix's fiscal year ends in December.
Where is Ocular Therapeutix based?
Ocular Therapeutix's address is: 24 Crosby Drive, Bedford, MA, United States, 01730
What is Ocular Therapeutix's ISIN number?
Ocular Therapeutix's international securities identification number is: US67576A1007
What is Ocular Therapeutix's CUSIP number?
Ocular Therapeutix's Committee on Uniform Securities Identification Procedures number is: 67576A100

More guides on Finder

Ask an Expert

You are about to post a question on

  • We cannot provide you with personal advice or recommendations


Go to site